These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 37361050)
21. GADD45B Transcript Is a Prognostic Marker in Papillary Thyroid Carcinoma Patients Treated With Total Thyroidectomy and Radioiodine Therapy. Barros-Filho MC; de Mello JBH; Marchi FA; Pinto CAL; da Silva IC; Damasceno PKF; Soares MBP; Kowalski LP; Rogatto SR Front Endocrinol (Lausanne); 2020; 11():269. PubMed ID: 32425887 [TBL] [Abstract][Full Text] [Related]
22. Bioinformatics analysis of the prognostic and clinical value of senescence-related gene signature in papillary thyroid cancer. Wen T; Guo S Medicine (Baltimore); 2023 Jun; 102(22):e33934. PubMed ID: 37266618 [TBL] [Abstract][Full Text] [Related]
23. Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus. Kang YY; Li JJ; Sun JX; Wei JX; Ding C; Shi CL; Wu G; Li K; Ma YF; Sun Y; Qiao H Clin Transl Oncol; 2021 Dec; 23(12):2536-2547. PubMed ID: 34245428 [TBL] [Abstract][Full Text] [Related]
24. Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma. Shi J; Wu P; Sheng L; Sun W; Zhang H Cancer Cell Int; 2021 Dec; 21(1):669. PubMed ID: 34906147 [TBL] [Abstract][Full Text] [Related]
25. Low expression of Yang L; Zhang X; Zhang J; Liu Y; Ji T; Mou J; Fang X; Wang S; Chen J Future Oncol; 2022 Jan; 18(3):333-348. PubMed ID: 34756116 [TBL] [Abstract][Full Text] [Related]
26. A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma. Qian X; Tang J; Li L; Chen Z; Chen L; Chu Y Bioengineered; 2021 Dec; 12(1):2341-2351. PubMed ID: 34077308 [TBL] [Abstract][Full Text] [Related]
27. Construction of a Signature Model to Predict the Radioactive Iodine Response of Papillary Thyroid Cancer. Liu L; Shi Y; Lai Q; Huang Y; Jiang X; Liu Q; Huang Y; Xia Y; Xu D; Jiang Z; Tu W Front Endocrinol (Lausanne); 2022; 13():865909. PubMed ID: 35634509 [TBL] [Abstract][Full Text] [Related]
28. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
29. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma. Dai K; Liu C; Guan G; Cai J; Wu L BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781 [TBL] [Abstract][Full Text] [Related]
30. Development and validation of a three-immune-related gene signature prognostic risk model in papillary thyroid carcinoma. Gan X; Guo M; Chen Z; Li Y; Shen F; Feng J; Cai W; Xu B J Endocrinol Invest; 2021 Oct; 44(10):2153-2163. PubMed ID: 33620716 [TBL] [Abstract][Full Text] [Related]
31. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis. Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884 [TBL] [Abstract][Full Text] [Related]
32. Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer. Ma B; Jiang H; Wen D; Hu J; Han L; Liu W; Xu W; Shi X; Wei W; Liao T; Wang Y; Lu Z; Wang Y; Ji Q J Clin Endocrinol Metab; 2019 Sep; 104(9):3713-3725. PubMed ID: 30942873 [TBL] [Abstract][Full Text] [Related]
33. Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma. Qin R; Li C; Wang X; Zhong Z; Sun C Cancer Cell Int; 2021 Jul; 21(1):378. PubMed ID: 34266418 [TBL] [Abstract][Full Text] [Related]
34. Development and validation of a novel 14-gene signature for predicting lymph node metastasis in papillary thyroid carcinoma. Ling Y; Jia L; Li K; Zhang L; Wang Y; Kang H Gland Surg; 2021 Sep; 10(9):2644-2655. PubMed ID: 34733714 [TBL] [Abstract][Full Text] [Related]
35. OGDHL closely associates with tumor microenvironment and can serve as a prognostic biomarker for papillary thyroid cancer. Mao M; Huang RZ; Zheng J; Liang HQ; Huang WH; Liu J; Li JH Cancer Med; 2021 Jan; 10(2):728-736. PubMed ID: 33405394 [TBL] [Abstract][Full Text] [Related]
36. A novel RNA sequencing-based risk score model to predict papillary thyroid carcinoma recurrence. He J; Tian Z; Yao X; Yao B; Liu Y; Yang J Clin Exp Metastasis; 2020 Apr; 37(2):257-267. PubMed ID: 31792675 [TBL] [Abstract][Full Text] [Related]
37. Screening and validation of lymph node metastasis risk-factor genes in papillary thyroid carcinoma. Zhang Q; Li J; Shen H; Bai X; Zhang T; Liu P Front Endocrinol (Lausanne); 2022; 13():991906. PubMed ID: 36465624 [TBL] [Abstract][Full Text] [Related]
38. A novel necroptosis-related gene signature associated with immune landscape for predicting the prognosis of papillary thyroid cancer. Wang Z; Wu P; Shi J; Ji X; He L; Dong W; Wang Z; Zhang H; Sun W Front Genet; 2022; 13():947216. PubMed ID: 36186479 [No Abstract] [Full Text] [Related]
39. Role of global aberrant alternative splicing events in papillary thyroid cancer prognosis. Lin P; He RQ; Huang ZG; Zhang R; Wu HY; Shi L; Li XJ; Li Q; Chen G; Yang H; He Y Aging (Albany NY); 2019 Apr; 11(7):2082-2097. PubMed ID: 30986203 [TBL] [Abstract][Full Text] [Related]